Senolytic selectivity needs testing
Patent application US20230330058A1 describes compounds intended to selectively kill senescent cells, but the supplied excerpt provides no quantitative selectivity data or experimental conditions.
Senolytic selectivity needs testing
Patent application US20230330058A1 describes compounds intended to kill senescent cells selectively while sparing non-senescent cells. That aim matches the definition of senolytics.
The supplied excerpt establishes the application's subject, but provides no quantitative selectivity data, doses, exposure times, or cell models. Assessing the claimed activity requires checking whether the authors compared death in senescent and non-senescent cells under matched conditions and how they measured cell death.
Senolytic compounds and compositions
Sources
[1] US20230330058A1 - Senolytic compounds and compositions
The connection rests on an exact mechanistic match and gives readers a concrete question to inspect in the application: whether matched experiments support selective cell killing.